CD44 Cancer Research Results
CD44, CD44: Click to Expand ⟱
| Source: |
| Type: |
CD44 represents a common biomarker of cancer stem cells, and promotes epithelial-mesenchymal transition. CD44 is a well-known marker of CSCs and plays important roles in tumor initiation and development.
|
Ovarian, Ovarian Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
CSCs↓, TumCG↓, TumMeta↓, CD44↓, CD34↓, OCT4↓, NOTCH1↓, HEY1↓,
| - |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
ROS↑, CSCs↓, CD44↓, SOX2↓, cMyc↓, TumMeta↓, TumCI↓, TumCMig↓, CD133↓, Nanog↓,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1,
Cell Death ⓘ
HEY1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
CD133↓, 1, CD34↓, 1, CD44↓, 2, CSCs↓, 2, Nanog↓, 1, NOTCH1↓, 1, OCT4↓, 1, SOX2↓, 1, TumCG↓, 1,
Migration ⓘ
TumCI↓, 1, TumCMig↓, 1, TumMeta↓, 2,
Total Targets: 15
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CD44, CD44
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:20 Cells:% prod#:% Target#:48 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page